Arena Capital Advisors’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-110,601
Closed -$140K 47
2023
Q3
$140K Sell
110,601
-72,121
-39% -$91.7K 0.17% 17
2023
Q2
$227K Sell
182,722
-243,666
-57% -$217K 0.76% 18
2023
Q1
$367K Hold
426,388
0.51% 26
2022
Q4
$264K Hold
426,388
0.14% 60
2022
Q3
$277K Hold
426,388
0.08% 102
2022
Q2
$330K Hold
426,388
0.08% 109
2022
Q1
$542K Sell
426,388
-11,542
-3% -$14.6K 0.08% 132
2021
Q4
$771K Sell
437,930
-211,080
-33% -$468K 0.07% 182
2021
Q3
$1.4M Buy
+649,010
New +$1.49M 0.11% 174

Other funds holding CLBTW

Arena Capital Advisors's CLBTW Position: Q4 2023 in Review

Arena Capital Advisors sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q4 2023, closing a stake of 110,601 shares — an estimated $140K sold.

Arena Capital Advisors first reported a position in CLBTW in Q3 2021 and held it in 9 quarters. The position peaked at $1.4M in Q3 2021. 19 funds tracked by Wall St. Rank hold CLBTW as of Q4 2023.

  • Arena Capital Advisors reported no remaining Cellebrite DI Ltd. Warrants position as of Q4 2023 after selling out during the quarter.
  • Arena Capital Advisors sold 110,601 Cellebrite DI Ltd. Warrants shares in Q4 2023, an estimated $140K.
  • Arena Capital Advisors first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 9 quarters.
  • Arena Capital Advisors's Cellebrite DI Ltd. Warrants position peaked at $1.4M in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q4 2023.

Based on Arena Capital Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.